Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2006-06-28 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13007), Bouches-du-Rhone
PHARMACIE SAINT LAMBERT : revenue, balance sheet and financial ratios
PHARMACIE SAINT LAMBERT is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13007),
this company of category PME
shows in 2021 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SAINT LAMBERT (SIREN 490876646)
Indicator
2024
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 328 384 €
1 253 132 €
1 303 982 €
1 366 468 €
1 286 276 €
1 304 449 €
Net income
23 291 €
84 730 €
99 935 €
306 148 €
102 602 €
100 748 €
73 144 €
96 986 €
EBITDA
N/C
N/C
139 792 €
101 787 €
138 399 €
139 142 €
108 184 €
120 009 €
Net margin
N/C
N/C
7.5%
24.4%
7.9%
7.4%
5.7%
7.4%
Revenue and income statement
In 2024, PHARMACIE SAINT LAMBERT generates positive net income of 23 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 97 k€ -> 23 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
23 291 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
16.578%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
76.807%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE SAINT LAMBERT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
Debt ratio
209.835
145.695
104.171
71.834
53.019
39.063
29.749
16.578
Financial autonomy
26.574
32.827
41.277
50.237
58.714
64.492
69.822
76.807
Repayment capacity
6.162
7.336
5.014
4.009
17.385
3.882
None
None
Cash flow / Revenue
7.903%
5.804%
7.247%
7.959%
2.155%
7.464%
None%
None%
Sector positioning
Debt ratio
16.582024
2021
2022
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good
In 2024, the debt ratio of PHARMACIE SAINT LAMBERT (16.58) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
76.81%2024
2021
2022
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+5 pts over 3 years
In 2024, the financial autonomy of PHARMACIE SAINT LAMBERT (76.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
3.88 years2021
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Average
In 2021, the repayment capacity of PHARMACIE SAINT LAMBERT (3.88) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 151.62. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
151.617
Liquidity indicators evolution PHARMACIE SAINT LAMBERT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
Liquidity ratio
94.511
90.057
108.99
125.676
180.554
188.63
207.674
151.617
Interest coverage
12.097
9.861
5.158
9.523
7.616
6.028
None
None
Sector positioning
Liquidity ratio
151.622024
2021
2022
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-14 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE SAINT LAMBERT (151.62) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
6.03x2021
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Excellent
In 2021, the interest coverage of PHARMACIE SAINT LAMBERT (6.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE SAINT LAMBERT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
Operating WCR
93 477 €
67 838 €
118 828 €
137 635 €
194 223 €
156 709 €
0 €
0 €
Inventory turnover (days)
42
40
38
39
43
46
0
0
Customer payment term (days)
7
7
10
11
11
7
0
0
Supplier payment term (days)
37
41
37
37
51
38
0
0
Positioning of PHARMACIE SAINT LAMBERT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE SAINT LAMBERT is estimated at
325 159 €
(range 226 435€ - 486 457€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
226k€325k€486k€
325 159 €Range: 226 435€ - 486 457€
NAF 5 année 2024
Valuation method used
Net Income Multiple
23 291 €
×
14.0x
=325 160 €
Range: 226 436€ - 486 457€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SAINT LAMBERT with other companies in the same sector:
Frequently asked questions about PHARMACIE SAINT LAMBERT
What is the revenue of PHARMACIE SAINT LAMBERT ?
The revenue of PHARMACIE SAINT LAMBERT in 2021 is 1.3 M€.
Is PHARMACIE SAINT LAMBERT profitable?
Yes, PHARMACIE SAINT LAMBERT generated a net profit of 23 k€ in 2024.
Where is the headquarters of PHARMACIE SAINT LAMBERT ?
The headquarters of PHARMACIE SAINT LAMBERT is located in MARSEILLE (13007), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE SAINT LAMBERT ?
The tax return of PHARMACIE SAINT LAMBERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SAINT LAMBERT operate?
PHARMACIE SAINT LAMBERT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart